Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Trastuzumab Biosimilar Antibody (Anti-HER2)

Isotype:
IgG1

$143.00

+ 143 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay
SDS-PAGE for Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade

Trastuzumab Biosimilar Antibody (Anti-HER2)

Product name Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
Source DrugBank DB00072 
Species Human
Molecular weight 145kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference PX-TA1005
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1
Clonality Monoclonal Antibody
Product name Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
Source DrugBank DB00072 
Species Human
Molecular weight 145kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference PX-TA1005
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1
Clonality Monoclonal Antibody

Trastuzumab Biosimilar Antibody

The trastuzumab biosimilar antibody is a recombinant anti-HER2 monoclonal antibody designed for research applications. HER2 (Human Epidermal Growth Factor Receptor 2) is a transmembrane receptor involved in cell proliferation and signaling pathways, making it a widely studied target in oncology and cell biology.

This trastuzumab biosimilar enables researchers to investigate HER2-mediated signaling, receptor binding, and antibody interactions in controlled experimental settings. It is suitable for laboratories working on antibody characterization, cell-based assays, and oncology-related research.

Biological Background

HER2 belongs to the epidermal growth factor receptor (EGFR) family and plays a key role in regulating cell growth and differentiation. Overexpression of HER2 has been extensively studied in cancer biology, making it an important target in research involving receptor signaling and antibody-based mechanisms.

Trastuzumab antibodies are commonly used in experimental studies to evaluate:

  • HER2 receptor binding and activation
  • antibody–antigen interactions
  • cell signaling pathways
  • oncology and targeted antibody research

Applications

The trastuzumab antibody is suitable for a wide range of research applications, including:

  • ELISA and binding assays
  • cell-based functional assays
  • antibody characterization studies
  • protein–protein interaction analysis
  • oncology and HER2-related research

Related Services

Researchers working with therapeutic antibodies and biosimilars may benefit from ProteoGenix expertise in:

Other Therapeutic Antibodies

Trastuzumab Price and Cost

ProteoGenix offers trastuzumab biosimilar antibodies at competitive market prices, allowing research laboratories to access high-quality reagents while optimizing project budgets.

Our biosimilar antibodies are produced under controlled conditions to ensure consistent quality, reproducibility, and cost-effective use in research applications.

CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay

CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay

Immobilized CD340 Recombinant Protein (cat. No.PX-P4121) at 0.5µg/mL (100µL/well) can bind Trastuzumab Biosimilar - Anti-HER2 mAb (cat. No.PX-TA1005) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 662.9M.

SDS-PAGE for Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade

SDS-PAGE for Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade

Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue.. The purity of the antibody is greater than 95%.

  • Chemical coupling of biological magnetosomes with amine-functionalized therapeutic antibody conjugates, S.M Payan, L Gandarias, R Avellan, D Faivre, S Prévéral, bioRxiv 2025.02.10.637426; doi: https://doi.org/10.1101/2025.02.10.637426

There are no reviews yet.

Be the first to review “Trastuzumab Biosimilar Antibody (Anti-HER2)”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products